Clinical Evaluation of Continuous Dual Aspiration Technique With Zoom System for Stroke (ADAPT 2.0)
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject is ≥ 18 years of age
• Subject or legally authorized representative has provided written informed consent prior to any study-specific procedures and no later than 72 hours after the index procedure
• Pre-stroke mRS 0-2
• Subject is undergoing or has undergone an aspiration thrombectomy using the Zoom System with Continuous Dual Aspiration Technique (CDAT) as the first line device within its intended use
Locations
United States
Alabama
Huntsville Hospital
RECRUITING
Huntsville
California
John Muir Health
NOT_YET_RECRUITING
Walnut Creek
Florida
University of South Florida
RECRUITING
Tampa
New York
Albany Medical College
NOT_YET_RECRUITING
Albany
South Carolina
Prisma Health - Upstate
RECRUITING
Greenville
Tennessee
Semmes Murphey Foundation
NOT_YET_RECRUITING
Memphis
Texas
University of Texas Science Health Center at San Antonio
NOT_YET_RECRUITING
San Antonio
Contact Information
Primary
Pojai Phattanagosai
pphattanagosai@Imperativecare.com
650-740-7703
Backup
Emma Pham
epham@imperativecare.com
408-421-7684
Time Frame
Start Date: 2026-03-24
Estimated Completion Date: 2030-06-01
Participants
Target number of participants: 750
Treatments
ADAPT 2.0: Zoom System with Continuous Dual Aspiration Technique (CDAT)
The Zoom System is intended to be used as the first-line device and utilized within the FDA-cleared indications for use, consistent with the approved labeling and intended anatomical targets.
Related Therapeutic Areas
Sponsors
Leads: Imperative Care, Inc.